Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - 16.71x - - - - 66Cr
2.66%2.73%64.91x6.09x5.24x19.49x26.09x 31TCr
1.72%1.78%23.09x1.93x3.18x11.34x18.71x 6.78TCr
2.59%2.77%17.18x1.49x2.19x7.5x8.97x 855.86Cr
-.--%-.--%21.18x5.63x6x16.95x17.72x 418.16Cr
0.79%0.79%39.31x2.34x2.22x27.39x41.35x 355.05Cr
-.--%-.--%107.96x - - - - 278.82Cr
4.08%3.52%17.33x0.76x1.36x24.3x41.6x 106.33Cr
-.--%-.--%-6.77x11.16x278.68x-5.97x-3.81x 88Cr
Average 1.48% 1.45% 33.43x 4.20x 42.70x 14.43x 21.52x 4.49TCr
Weighted average by Cap. 2.44% 2.5% 56.15x 5.24x 5.40x 17.86x 24.50x
Specialty & Advanced Pharmaceuticals